286 related articles for article (PubMed ID: 15759171)
1. Drug price regulation under consumer moral hazard. Two-part tariffs, uniform price or third-degree price discrimination?
Felder S
Eur J Health Econ; 2004 Dec; 5(4):324-9. PubMed ID: 15759171
[TBL] [Abstract][Full Text] [Related]
2. Pharmaceutical pricing, price controls, and their effects on pharmaceutical sales and research and development expenditures in the European Union.
Vogel RJ
Clin Ther; 2004 Aug; 26(8):1327-40; discussion 1326. PubMed ID: 15476914
[TBL] [Abstract][Full Text] [Related]
3. Impact of European pharmaceutical price regulation on generic price competition: a review.
Puig-Junoy J
Pharmacoeconomics; 2010; 28(8):649-63. PubMed ID: 20515079
[TBL] [Abstract][Full Text] [Related]
4. The economics of parallel trade.
Danzon PM
Pharmacoeconomics; 1998 Mar; 13(3):293-304. PubMed ID: 10178655
[TBL] [Abstract][Full Text] [Related]
5. European healthcare policies for controlling drug expenditure.
Ess SM; Schneeweiss S; Szucs TD
Pharmacoeconomics; 2003; 21(2):89-103. PubMed ID: 12515571
[TBL] [Abstract][Full Text] [Related]
6. Pharmaceutical pricing: an empirical study of market competition in Chinese hospitals.
Wu J; Xu J; Liu G; Wu J
Pharmacoeconomics; 2014 Mar; 32(3):293-303. PubMed ID: 24190661
[TBL] [Abstract][Full Text] [Related]
7. Examining the link between price regulation and pharmaceutical R&D investment.
Vernon JA
Health Econ; 2005 Jan; 14(1):1-16. PubMed ID: 15386673
[TBL] [Abstract][Full Text] [Related]
8. Competitive pricing within pharmaceutical classes: evidence on "follow-on" drugs in Germany 1993-2008.
Mueller MT; Frenzel A
Eur J Health Econ; 2015 Jan; 16(1):73-82. PubMed ID: 24370790
[TBL] [Abstract][Full Text] [Related]
9. Reimbursement for new health technologies. Breakthrough pharmaceuticals as a 20th century challenge.
Glynn D
Pharmacoeconomics; 2000; 18 Suppl 1():59-67. PubMed ID: 11151310
[TBL] [Abstract][Full Text] [Related]
10. Financial effects of pharmaceutical price regulation on R&D spending by EU versus US firms.
Golec J; Vernon JA
Pharmacoeconomics; 2010; 28(8):615-28. PubMed ID: 20617857
[TBL] [Abstract][Full Text] [Related]
11. Price regulation in the pharmaceutical industry: prescription or placebo?
Abbott TA
J Health Econ; 1995 Dec; 14(5):551-65. PubMed ID: 10156501
[TBL] [Abstract][Full Text] [Related]
12. Pricing and reimbursement of pharmaceuticals in the Czech Republic and Sweden.
Davidova J; Praznovcova L; Lundborg CS
Pharm World Sci; 2008 Jan; 30(1):57-64. PubMed ID: 17588212
[TBL] [Abstract][Full Text] [Related]
13. Comparative approaches to pharmaceutical price regulation in the European Union.
Mrazek MF
Croat Med J; 2002 Aug; 43(4):453-61. PubMed ID: 12187524
[TBL] [Abstract][Full Text] [Related]
14. A Case Study of Pharmaceutical Pricing in China: Setting the Price for Off-Patent Originators.
Hu S; Zhang Y; He J; Du L; Xu M; Xie C; Peng Y; Wang L
Appl Health Econ Health Policy; 2015 Aug; 13 Suppl 1(Suppl 1):S13-20. PubMed ID: 26091710
[TBL] [Abstract][Full Text] [Related]
15. [Drug prices: how they are established and existing price control systems].
Rovira Forns J
Salud Colect; 2015 Mar; 11(1):35-48. PubMed ID: 25853829
[TBL] [Abstract][Full Text] [Related]
16. [The aspects of pricing policy in Azerbaijan pharmaceutical sector].
Dzhalilova KI; Alieva KIa
Georgian Med News; 2012 Jan; (202):48-53. PubMed ID: 22392783
[TBL] [Abstract][Full Text] [Related]
17. [Risk sharing methods in middle income countries].
Inotai A; Kaló Z
Acta Pharm Hung; 2012; 82(1):43-52. PubMed ID: 22570986
[TBL] [Abstract][Full Text] [Related]
18. Competition and the Reference Pricing Scheme for pharmaceuticals.
Ghislandi S
J Health Econ; 2011 Dec; 30(6):1137-49. PubMed ID: 21937137
[TBL] [Abstract][Full Text] [Related]
19. Pricing, regulation, and competitiveness. Lessons for the US from the Japanese pharmaceutical industry.
Thomas LG
Pharmacoeconomics; 1994; 6 Suppl 1():67-70. PubMed ID: 10155588
[TBL] [Abstract][Full Text] [Related]
20. International trade and determinants of price differentials of insulin medicine.
Helble M; Aizawa T
Health Policy Plan; 2017 Feb; 32(1):1-10. PubMed ID: 27346189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]